Time to recognise countries' preferences in HIV control

Lancet. 2016 Mar 12;387(10023):1053-1054. doi: 10.1016/S0140-6736(16)00659-0.

Authors

Noor Tromp¹, Rozar Prawiranegara², Adiatma Siregar³, Maarten Paul Maria Jansen⁴, Rob Baltussen⁴

Affiliations

¹ Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, NL-6500 HB, Netherlands. Electronic address: [email protected].
² TB-HIV Research Center, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.
³ Faculty of Economics and Business, Padjadjaran University, Bandung, Indonesia.
⁴ Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, NL-6500 HB, Netherlands.

PMID: 27025180
DOI: 10.1016/S0140-6736(16)00659-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-HIV Agents / therapeutic use*
HIV Infections / prevention & control*
Humans

Substances

Anti-HIV Agents